Private Wealth Asset Management, LLC Travere Therapeutics, Inc. Transaction History
Private Wealth Asset Management, LLC
- $695 Billion
- Q1 2025
A detailed history of Private Wealth Asset Management, LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Private Wealth Asset Management, LLC holds 95 shares of TVTX stock, worth $2,009. This represents 0.0% of its overall portfolio holdings.
Number of Shares
95Holding current value
$2,009% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TVTX
# of Institutions
234Shares Held
99.3MCall Options Held
1.57MPut Options Held
555K-
Armistice Capital, LLC New York, NY8.87MShares$188 Million2.42% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$162 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X07.53MShares$159 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.01MShares$106 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C34.8MShares$101 Million0.11% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.36B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...